Form 4: OS Therapies Inc. Director Romness Receives 225,000 Shares from Escrow Following Lock-Up Agreement

Paul A. Romness, President and CEO of OS Therapies Inc., received 225,000 shares of common stock from escrow on February 28, 2025, following the terms of a transfer agreement related to the company's initial public offering.

Summary

• On February 28, 2025, Paul A. Romness, President and CEO of OS Therapies Inc., received 225,000 shares of the company's common stock.
• These shares were released from escrow as part of a Transfer Agreement related to the company's initial public offering.
• The Transfer Agreement, effective May 13, 2024, involved placing 600,000 shares in escrow in exchange for Einodmil LLC's participation in a pre-IPO lock-up agreement.
• The release of shares was contingent on the 20-day VWAP of OS Therapies' common stock.
• After the release, Romness directly owns 2,473,000 shares of OS Therapies Inc.
• The remaining 375,000 shares were released from escrow and transferred to Einodmil.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to the release of shares from escrow following an IPO lock-up period. It doesn't inherently indicate positive or negative sentiment, but rather a procedural event.

Positives

• The release of shares from escrow indicates the fulfillment of conditions related to the IPO lock-up agreement.
• Romness's continued direct ownership of 2,473,000 shares suggests a strong alignment with the company's success.

Industry Context

This Form 4 filing is a routine disclosure related to changes in beneficial ownership by a company insider, which is a common occurrence after an IPO and the expiration of lock-up agreements.

Stakeholder Impact

• The release of shares could have a minor impact on shareholders, potentially affecting the stock's supply and demand dynamics.

Key Dates